Cervical cancer Cancer Malignant neoplasm of cervix uteri
Conditions
Interventions
Current intervention as of 04/02/2022:
All the consenting women between 30 to 49 years of age (or 25-49 years of age according to the national protocol) attending the clinics for diffe
Sponsors
International Agency For Research On Cancer
The Foundation Lalla Salma Cancer Prevention and Treatment
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: All consenting women aged between 30 to 49 years (or 25-49) attending the primary health centers for different reasons will be offered VIA opportunistically
Exclusion criteria
Exclusion criteria: 1. Pregnant women 2. Women suffering from debilitating illnesses 3. Diagnosis of or previous invasive cervical cancer 4. Those screened for cervical cancer within the last 36 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Current primary outcome measure as of 04/02/2022: 1. Participation in screening for each woman reported using the screening questionnaire at the screening visit 2. VIA/HPV positivity rate: Proportion of women positive on VIA/HPV among the total screened: calculated using the data collected by a questionnaire to record the VIA status of each screened woman at the screening visit 3. Treatment rate: Proportion of VIA/HPV-positive women eligible for thermal ablation who complete treatment at the same screening visit: calculated using the data collected by a questionnaire to record the completion of treatment at the same screening visit among VIA/HPV positive woman eligible for thermal ablation 4. Colposcopy compliance rate: Proportion of VIA/HPV-positive women referred to colposcopy who actually had the procedure done: calculated using the data collected by a questionnaire to record at colposcopy referral visit the compliance to colposcopy by VIA/HPV positive woman referred to colposcopy 5. Cure rate after treatment: Proportion of women treated by thermal ablation detected to be VIA/HPV negative at one-year follow-up visit after treatment out of the total number treated and followed up: calculated using the data collected by a questionnaire to record the VIA/HPV status after one year of each treated woman by thermal ablation 6. Complication rate after treatment: Proportion of complications reported after thermal ablation treatment out of the women treated: calculated using the data of reported complications after thermal ablation and recorded on a questionnaire ______ Previous primary outcome measure: 1. Participation in screening for each woman reported using the screening questionnaire at the screening visit 2. VIA positivity rate: Proportion of women positive on VIA among the total screened: calculated using | — |
Secondary
| Measure | Time frame |
|---|---|
| There are no secondary outcome measures | — |
Countries
Benin, Cameroon, Cote d'Ivoire, Senegal
Contacts
Public ContactYoussef Chami Khazraji
Outcome results
None listed